Jan Asif, Mothana Ramzi A, Kaimori Jun-Ya, Muhammad Tahir, Khan Mehtab, Ali Syed Shaukat, Rahman Naveed, Alanzi Abdullah R
Asif Jan, District Headquarter Hospital (DHQH) Charsadda, Charsadda 24430, Pakistan. Department of Pharmacy, University of Peshawar, Peshawar 25000, Pakistan.
Ramzi A. Mothana, Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 1151, Saudi Arabia.
Pak J Med Sci. 2024 Nov;40(10):2336-2343. doi: 10.12669/pjms.40.10.10292.
Pakistan, a South Asian developing country, is experiencing a rapid increase in number of diabetes cases. High prevalence ratio of diabetes in Pakistani population and lack of genetic research studies prompted us to design this study. This present study investigated Pakistani Pashtun population for (known and novel SNPs) and its possible correlation with Type-2 Diabetes Mellitus (T2DM).
This two stage (discovery & validation stage), case-control association study included one thousand individuals (Patients with T2DM=500 & controls=500) from eight districts of Khyber Pakhtunkhwa Pakistan. The study duration/period was from March 2018 to January 2020. In the first stage (the discovery stage) the target population was screened for known and novel T2DM-associated genetic markers. In the validation stage, identified variants were confirmed for T2DM association using MassARRAY genotyping and association analysis.
Exome sequencing detected eleven known and four novel/new genetic markers in the study population. Novel variants were preferred over the known for follow-up analysis/validation. Among the identified variants strong associations were confirmed for the following variants; rs1781133/ (OR=2.10, 95%Cl=1.06-3.08, P=0.003) rs2274791/ (OR=1.97, 95%Cl=1.36-2.62, P=0.025), rs71628928/ (OR=1.82, 95%Cl=0.97-1.92, P=0.041), and rs609805/ (OR=2.21, 95%Cl=1.92-3.09, P=0.001) with T2DM; other reported variants showed no noticeable association (having P>0.05) with T2DM.
This study reports new genetic risk variants for T2DM in Pashtun population providing valuable insights into the genetic basis of T2DM in this group.
巴基斯坦是一个南亚发展中国家,糖尿病病例数正在迅速增加。巴基斯坦人群中糖尿病的高患病率以及缺乏基因研究促使我们开展这项研究。本研究调查了巴基斯坦普什图人群中的(已知和新型单核苷酸多态性)及其与2型糖尿病(T2DM)的可能相关性。
这项两阶段(发现与验证阶段)的病例对照关联研究纳入了来自巴基斯坦开伯尔-普赫图赫瓦省八个地区的1000名个体(T2DM患者=500名,对照组=500名)。研究持续时间为2018年3月至2020年1月。在第一阶段(发现阶段),对目标人群进行已知和新型T2DM相关基因标记的筛查。在验证阶段,使用MassARRAY基因分型和关联分析确认已鉴定变异与T2DM的关联。
外显子组测序在研究人群中检测到11个已知和4个新型基因标记。新型变异比已知变异更适合后续分析/验证。在已鉴定的变异中,确认了以下变异与T2DM有强关联;rs1781133/(比值比=2.10,95%置信区间=1.06 - 3.08,P=0.003),rs2274791/(比值比=1.97,95%置信区间=1.36 - 2.62,P=0.025),rs71628928/(比值比=1.82,95%置信区间=0.97 - 1.92,P=0.041),以及rs609805/(比值比=2.21,95%置信区间=1.92 - 3.09,P=0.001)与T2DM;其他报道的变异与T2DM无明显关联(P>0.05)。
本研究报告了普什图人群中T2DM的新遗传风险变异,为该群体中T2DM的遗传基础提供了有价值的见解。